Rahnella aquatilis bacteremia in a patient with relapsed acute lymphoblastic leukemia.
Rahnella aquatilis infections are rare. We report the case of a 46-y-old African-American male with relapsed acute lymphoblastic leukemia who had R. aquatilis bacteremia after beginning reinduction chemotherapy. He was treated for 4 weeks with piperacillin-tazobactam and gentamicin. He recovered from the infection and had an allogenic bone marrow transplant a month later.
Carinder
J E
JE
Department of Hematology and Medical Oncology Medicine, Cleveland Clinic Foundation, OH 44195, USA.
Chua
J D
JD
Corales
R B
RB
Taege
A J
AJ
Procop
G W
GW
D016470:Bacteremia / Q000188:drug therapy / Q000382:microbiology*; D016026:Bone Marrow Transplantation; D002051:Burkitt Lymphoma / Q000628:therapy*; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy / Q000382:microbiology*; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D010397:Penicillanic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D010878:Piperacillin / Q000627:therapeutic use; D000077725:Piperacillin, Tazobactam Drug Combination; D020638:Rahnella
D007166:Immunosuppressive Agents; D000077725:Piperacillin, Tazobactam Drug Combination; D010397:Penicillanic Acid; D010878:Piperacillin